BOSTON, May 18, 2022 /PRNewswire/ PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National
/PRNewswire/ PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration.
/PRNewswire/ PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration.
While some countries are gearing up to roll out COVID-19 booster shots, others are struggling to secure first-doses of the vaccine. Click to read more.